Price $0.26 |
Market Cap
18.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.47
|
P/S
42.51
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-65.7K
|
FCF
-1.5
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-139.60%
|
ROI
-138.20%
|
|
ROA
-77.30%
|
EPS Growth
18.40%
|
Current Ratio
2.0
|
Debt/Equity
30.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Surface Oncology Inc (SURF) | $1.15 | - | - | 62.1M | Strong Buy |
| Alimera Sciences Inc (ALIM) | $5.73 | - | - | 36.7M | Strong Buy |
| Societal CDMO Inc (SCTL) | $1.56 | - | - | 92.4M | Strong Buy |
| Greenrose Holding Company Inc (GNRS) | $1.25 | - | - | 23.8M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $2.47 | - | - | 36.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
